Taipei Veterans General Hospital

:::

羅景全 (Jiing-Chyuan Luo)

Return Appointment First Appointment

[Profile]

Education
Career and Experience
Current Positions：
- - Now, Attending Physician, Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan,
- - Now, Chief, Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan,
- - Now, Professor, Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan,
Experiences：
- - , Research Associate, Department of Pharmacology, Hong Kong University School of Medicine,
- - , Deputy Secretary-General, Digestive Endoscopy Society Taiwan,
- - , Chief Resident, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan,
- - , Resident, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan,
Medical Expertise
1. Gastroesophageal reflux disease
2. Helicobacter pylori infection and peptic ulcer disease
3. Diagnostic and therapeutic endoscopy
4. Inflammatory bowel disease
5. The mechanisms of GI mucosa protection, injury, and repair
6. Medication (aspirin, clopidogrel, steroid, NSAIDs), co-morbidity, and peptic ulcer disease/ peptic ulcer bleeding
License

Board-certified Physician, Diploma of Department of Health, Executive Yuan, Taiwan Board-certified Gastroenterologist and Instructor, Diploma of The Gastroenterological Society of Taiwan Board-certified Digestive Endoscopist and Instructor, Diploma of The Digestive Endoscopy Society of Taiwan

[Publications]

1. Luo JC*, Leu HB, Huang KW, et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ 2011;183:E1345-51.

2. Tseng CL, Chen YT, Huang CJ, Luo JC*, et al. Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover study. Aliment Pharmacol Ther 2015;42:599-606.

3. Lin XH,HuangKH,ChuangWH, Luo JC*, et al. The long term effect of metabolic profile and microbiota status in gastric cancer patients after subtotal gastrectomy. PLoS One 2018 Nov. 5;13(11):e0206930.

4. Chang TE,Luo JC^*,Yang UC, et al. Fecal microbiota profile in patients with inflammatory bowel disease in Taiwan. J Chin Med Assoc 2021;84: 580-587.

5. Liou JM, Jiang XT, Chen CC, Luo JC, Fang YJ, Bair MJ, Chen MJ, Chen CC, Lee JY, Yang TH, Chen PY, Chen CY, Chou CK,Shun CT, Hsu WF, Tseng CH, Hsu YC, Chang CY, Lin JT, El-Omar EM, Wu MS*, for the Taiwan Gastrointestinal Disease and Helicobacter Consortium. Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol. 2023;8(3):228-241.